5-hydroxytryptophan has been researched along with Headache, Tension in 2 studies
5-Hydroxytryptophan: The immediate precursor in the biosynthesis of SEROTONIN from tryptophan. It is used as an antiepileptic and antidepressant.
5-hydroxytryptophan : A tryptophan derivative that is tryptophan substituted by a hydroxy group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A parallel, randomized, double-blind trial is reported, in which 78 patients with chronic tension-type headaches were treated with L-5-hydroxytryptophan (5-HTP) (n = 43) or placebo (n = 35) for 8 weeks, after a washout period of 2 weeks and with a follow-up period of a further 2 weeks." | 9.09 | L-5-Hydroxytryptophan in the prophylaxis of chronic tension-type headache: a double-blind, randomized, placebo-controlled study. For the Portuguese Head Society. ( Ribeiro, CA, 2000) |
| "Interictal serum levels of serotonin and plasma and mononuclear cell concentrations of beta-endorphin were measured in 20 juvenile patients (13 suffering from migraine without aura and 7 from episodic tension-type headache) before and after 3 months of L-5-hydroxytryptophan treatment (5 mg/kg/day) and compared with a control group of 17 headache-free healthy subjects." | 9.08 | beta-endorphin in plasma and monocytes in juvenile headache. ( Battistella, PA; Bordin, A; Broetto, S; Cernetti, R; Corrà, S; Piva, E; Plebani, M, 1996) |
| "A parallel, randomized, double-blind trial is reported, in which 78 patients with chronic tension-type headaches were treated with L-5-hydroxytryptophan (5-HTP) (n = 43) or placebo (n = 35) for 8 weeks, after a washout period of 2 weeks and with a follow-up period of a further 2 weeks." | 5.09 | L-5-Hydroxytryptophan in the prophylaxis of chronic tension-type headache: a double-blind, randomized, placebo-controlled study. For the Portuguese Head Society. ( Ribeiro, CA, 2000) |
| "Interictal serum levels of serotonin and plasma and mononuclear cell concentrations of beta-endorphin were measured in 20 juvenile patients (13 suffering from migraine without aura and 7 from episodic tension-type headache) before and after 3 months of L-5-hydroxytryptophan treatment (5 mg/kg/day) and compared with a control group of 17 headache-free healthy subjects." | 5.08 | beta-endorphin in plasma and monocytes in juvenile headache. ( Battistella, PA; Bordin, A; Broetto, S; Cernetti, R; Corrà, S; Piva, E; Plebani, M, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Battistella, PA | 1 |
| Bordin, A | 1 |
| Cernetti, R | 1 |
| Broetto, S | 1 |
| Corrà, S | 1 |
| Piva, E | 1 |
| Plebani, M | 1 |
| Ribeiro, CA | 1 |
2 trials available for 5-hydroxytryptophan and Headache, Tension
| Article | Year |
|---|---|
beta-endorphin in plasma and monocytes in juvenile headache.
Topics: 5-Hydroxytryptophan; Adolescent; Adult; beta-Endorphin; Child; Female; Headache; Humans; Male; Migra | 1996 |
L-5-Hydroxytryptophan in the prophylaxis of chronic tension-type headache: a double-blind, randomized, placebo-controlled study. For the Portuguese Head Society.
Topics: 5-Hydroxytryptophan; Adolescent; Adult; Chronic Disease; Double-Blind Method; Female; Humans; Incide | 2000 |